South Korea vs Norway: Measles-containing-vaccine second-dose (MCV2) immunization coverage
South Korea
95.0%
in 2025
Norway
95.0%
in 2025
South Korea rank
29th
Norway rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- South Korea
- Norway
How they compare
South Korea currently reports 95.0% against 95.0% in Norway, a difference of 0.0%.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was Norway ahead.
South Korea ranks 29th and Norway ranks 29th of 194 countries.
Across the 3 decades both report, South Korea averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | South Korea | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.0% | 91.5% | 2.5% | Norway |
| 2010s | 96.8% | 92.6% | 4.2% | South Korea |
| 2020s | 95.3% | 94.5% | 0.8% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, South Korea or Norway?
- South Korea, at 95.0% against 95.0% in Norway as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between South Korea and Norway?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Norway?
- 26 years are reported by both, from 2000 to 2025.
- How do South Korea and Norway rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- South Korea ranks 29th and Norway ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.